Nefegan Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Budesonide

Indications/Uses

Reduces loss of kidney function in adults w/ primary IgA nephropathy who are at risk for disease progression w/ urine protein excretion ≥1 g daily (or urine protein-to-creatinine ratio ≥0.8 g/g).

Dosage/Direction for Use

16 mg once daily. Reduce dose to 8 mg once daily for the last 2 wk when discontinuing therapy. Duration of therapy: 9 mth.

Administration

Should be taken on an empty stomach: Swallow whole in the morning at least 1 hr before a meal, do not open/crush/chew.

Contraindications

Hypersensitivity. Serious hypersensitivity reactions including anaphylaxis w/ other budesonide formulations.

MIMS Class

Other Drugs Acting on the Genito-Urinary System

ATC Classification

A07EA06 - budesonide ; Belongs to the class of corticosteroids acting locally. Used in the treatment of intestinal inflammation.

Regulatory Classification

POM

Presentation/Packing

Form

Nefegan cap 4 mg

Packing/Price

1's

Nefegan

budesonide

Manufacturer:

Patheon